info icon

This is a non-core endpoint: only basic statistics are computed.

Melanoma in situ of lower limb, including hip

CD2_INSITU_MELANOMA_LOWERLIMB_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D03.7&
  • Cause of death: ICD-10 D03.7&

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D03
Name in latin
Melanoma in situ coxae

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 200 152 48
Unadjusted period prevalence (%) 0.04 0.05 0.02
Median age at first event (years) 64.05 62.01 70.52

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
173
Matched controls
1729
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
+∞
250.2
173
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
259.0
123.2
115
13
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
+∞
47.0
43
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
18.1
41.8
69
61
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
75.9
37.1
41
7
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
21.6
32.2
48
30
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
23.6
31.9
46
26
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
18.5
31.6
50
37
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
25.6
24
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
263.1
23.2
23
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
131.6
22.1
23
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
15.3
21.6
36
29
R23.8
ICD-10 Finland
Other and unspecified skin changes
6.6
20.9
61
132
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
224.4
20.0
20
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
18.0
17
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
18.0
17
*
D22
ICD-10 Finland
Melanocytic naevi
16.4
17.5
28
20
L57.0
ICD-10 Finland
Actinic keratosis
7.6
16.6
41
68
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
15.9
15
*
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
15.9
15
*
S18
ICPC
Laceration/cut
3.7
15.3
105
506
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
20.8
15.1
22
12
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
14.8
14
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
14.8
14
*
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
81.3
13.8
15
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.1
13.6
31
45
ZZR00
NOMESCO Finland
Flap of skin
75.5
12.8
14
*
ZZA00
NOMESCO Finland
Split skin graft
13.9
12.5
21
17
S77
ICPC
Malignant neoplasm of skin
69.7
11.8
13
*
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
+∞
11.6
11
*
115
Kela drug reimbursment
Breast cancer
+∞
11.6
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.6
11
*
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
+∞
11.6
11
*
D03.5
ICD-10 Finland
Melanoma in situ of trunk
128.0
11.6
12
*
TQW99
NOMESCO Finland
Other minor procedure on skin
8.4
10.6
23
31
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
10.5
10
*
L82
ICD-10 Finland
Seborrhoeic keratosis
3.8
9.7
45
147
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
23.2
9.5
13
6
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.5
9
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
9.5
9
*
130
Kela drug reimbursment
Malignant tumour
+∞
9.5
9
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
9.5
9
*
HAC20
NOMESCO Finland
Total mastectomy
94.4
8.5
9
*
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
+∞
8.4
8
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
8.4
8
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
8.4
8
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
8.4
8
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
8.4
8
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
8.4
8
*
8720/2-C44.7
ICD-O-3
Melanoma in situ of skin of lower limb and hip
+∞
8.4
8
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
8.4
8
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
8.4
8
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
8.4
8
*
JN4BD
NOMESCO Finland
Extensive body CT
6.1
8.0
21
38
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
26.3
7.7
10
*
ZXC20
NOMESCO Finland
Use of chemical agents
26.3
7.7
10
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
26.3
7.7
10
*
ZXC50
NOMESCO Finland
Cryotherapy
14.2
7.5
12
9
C61
ICD-10 Finland
Malignant neoplasm of prostate
83.4
7.5
8
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
7.3
7
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
7.3
7
*
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
+∞
7.3
7
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
7.3
7
*
JN4AD
NOMESCO Finland
Body CT examination
8.5
7.3
15
19
S82
ICPC
Naevus/mole
3.4
7.1
35
119
XQ848
NOMESCO Finland
Dermatological photography
9.9
6.9
13
14
SPAT1153
SPAT
Removal of sutures
2.4
6.5
71
388
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
72.3
6.5
7
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
72.3
6.5
7
*
D06BB10
ATC
imiquimod; topical
6.7
6.3
15
24
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
+∞
6.3
6
*
H02AB02
ATC
dexamethasone; systemic
10.6
6.1
11
11

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
111
118
19.89
104.44
1.9
1.1
—
—
—
0
0
60
52
16.05
61.44
1.5
1.3
—
—
—
0
0
174
569
16.83
61.27
4.3
1.7
—
—
—
0
0
32
73
5.03
13.65
1.6
1.2
—
—
—
0
0
123
869
2.08
5.84
9.8
6.5
3.9
4.1
e9/l
0.48
109
757
80
499
2.01
5.22
8.9
5.4
—
—
—
0
0
10
20
5.21
4.83
1.2
1.2
—
—
—
0
0
111
821
1.79
3.96
8.6
5.6
0.2
0.2
e9/l
0.19
100
721
38
205
2.05
3.57
1.4
1.4
—
—
—
0
0
17
65
2.77
3.40
3.4
7.4
23.7
25.0
mmol/l
1.50
17
59
194
1802
3.55
3.31
12.5
8.7
24.5
24.3
u/l
0.10
188
1721
69
464
1.74
3.28
3.5
2.9
7.4
7.4
ph
0.32
13
60
105
792
1.69
3.27
8.4
5.0
0.6
0.6
e9/l
0.78
94
688
106
803
1.68
3.24
8.4
5.2
1.9
1.9
e9/l
0.07
96
706
11
33
3.47
3.24
1.2
1.1
—
—
—
0
0
95
701
1.68
3.20
4.8
4.7
1.2
1.2
mmol/l
0.54
89
627
105
796
1.67
3.18
8.5
5.0
0.0
0.0
e9/l
0.55
94
688
54
345
1.77
3.04
8.5
4.8
—
—
—
0
0
36
202
1.95
3.03
2.5
2.2
0.8
0.8
mmol/l
0.17
36
187
59
389
1.73
2.97
3.5
2.6
—
—
—
0
0
63
425
1.70
2.92
2.3
1.9
—
—
—
0
0
5
6
8.50
2.76
1.2
1.0
—
—
—
0
0
7
14
5.14
2.75
1.9
1.3
—
—
—
0
0
36
209
1.88
2.74
1.8
1.7
—
—
—
0
0
147
1242
1.69
2.73
9.1
5.0
74.6
75.3
u/l
0.13
141
1133
18
80
2.37
2.70
4.2
1.6
19.7
30.1
u/ml
0.36
18
75
31
174
1.92
2.61
1.7
1.3
—
—
—
0
0
97
747
1.58
2.59
9.5
5.4
27.1
28.5
%
0.66
91
685
72
519
1.61
2.53
1.9
2.0
327.3
282.6
u/l
0.07
66
483
0
63
0.00
2.47
0.0
4.8
—
1.3
—
0
63
59
411
1.62
2.36
3.5
2.7
0.4
0.4
e6/l
0.08
41
297
63
447
1.60
2.34
3.1
2.7
9.9
199.4
e6/l
0.69
45
333
73
541
1.55
2.24
3.8
3.4
27.3
129.7
e6/l
2.73
47
363
14
61
2.39
2.20
4.4
8.3
—
—
—
0
0
7
20
3.59
2.07
1.1
1.4
—
—
—
0
0
29
175
1.77
1.96
3.7
2.5
0.8
0.7
ug/l
0.29
21
116
51
358
1.57
1.95
1.5
1.3
—
—
—
0
0
5
11
4.63
1.95
1.2
1.0
—
—
—
0
0
5
11
4.63
1.95
1.4
1.3
—
—
—
0
0
68
514
1.49
1.85
4.3
2.0
2.3
2.4
mmol/l
0.51
60
422
15
75
2.08
1.74
4.7
5.3
24.5
25.1
mmol/l
0.31
15
75
86
691
1.43
1.68
12.4
7.7
0.0
0.0
e9/l
0.47
69
569
179
1658
1.76
1.67
16.9
11.5
23.6
19.6
mg/l
0.73
139
1238
7
25
2.86
1.66
3.1
1.8
—
—
—
0
0
27
173
1.65
1.50
1.7
1.6
—
—
—
0
0
9
38
2.43
1.47
1.9
1.8
—
—
—
0
0
22
134
1.72
1.46
1.6
1.4
—
—
—
0
0
17
96
1.84
1.44
1.2
1.2
—
—
—
0
0
186
1755
1.85
1.43
4.8
5.3
2.7
2.8
mmol/l
0.77
172
1612
12
60
2.06
1.41
1.2
1.2
—
—
—
0
0
50
374
1.45
1.40
4.9
3.3
—
—
—
0
0
18
105
1.78
1.38
4.6
6.6
—
—
—
0
0
6
23
2.66
1.38
1.2
1.2
—
—
—
0
0
49
367
1.44
1.37
4.1
1.7
5.6
1.0
mg/l
0.56
35
288
183
1723
1.73
1.35
4.1
4.7
4.6
4.7
mmol/l
0.94
171
1594
163
1498
1.48
1.32
20.0
13.1
40.3
39.7
%
0.80
118
1037
19
115
1.72
1.30
4.6
5.1
1.2
1.4
mmol/l
0.40
19
109
41
300
1.46
1.29
2.9
2.1
2.7
6.2
e6/l
2.97
35
261
188
1789
1.85
1.25
18.9
13.4
76.2
74.9
umol/l
0.27
188
1789
54
419
1.40
1.24
1.6
1.5
25.6
21.7
nmol/l
1.01
47
369
48
365
1.41
1.23
4.3
3.8
—
—
—
0
0
33
234
1.49
1.21
2.9
2.3
12.9
13.8
umol/l
0.31
27
212
29
200
1.53
1.21
3.0
2.3
2.1
2.4
g/l
1.64
24
185
127
1128
1.34
1.20
5.3
4.2
—
—
—
0
0
6
26
2.35
1.19
1.7
1.1
—
—
—
0
0
11
57
1.98
1.19
4.4
1.8
592.2
965.5
ug/l
0.17
11
50
0
33
0.00
1.17
0.0
2.2
—
4.1
—
0
33
0
33
0.00
1.17
0.0
2.2
—
106.2
—
0
33
0
33
0.00
1.17
0.0
2.2
—
—
—
0
0
181
1711
1.61
1.16
4.6
4.7
5.7
5.9
mmol/l
3.61
167
1561
5
20
2.54
1.16
1.4
1.3
—
—
—
0
0
0
36
0.00
1.15
0.0
1.1
—
—
—
0
0
39
291
1.42
1.11
2.4
2.4
583.7
525.6
mosm/kgh2o
0.69
31
238
24
163
1.54
1.08
1.4
2.1
4.7
5.5
umol/l
0.65
18
139
52
413
1.35
1.03
2.4
2.2
353.7
8647.4
umol/l
2.46
46
355
5
23
2.20
0.98
5.8
2.3
—
—
—
0
0
180
1711
1.52
0.98
4.1
4.7
1.6
1.5
mmol/l
0.11
168
1575
6
28
2.18
0.92
4.3
2.0
5.3
5.0
kpa
—
6
28
6
28
2.18
0.92
4.3
2.0
8.0
8.3
kpa
—
6
28
6
28
2.18
0.92
4.3
2.0
-0.2
3.0
mmol/l
—
6
13
12
71
1.73
0.91
1.4
1.4
—
—
—
0
0
22
153
1.49
0.90
2.0
1.4
—
—
—
0
0
6
29
2.10
0.90
1.7
1.1
—
—
—
0
0
19
128
1.54
0.90
1.5
1.4
—
—
—
0
0
15
96
1.61
0.87
1.3
1.2
282.8
189.8
u/ml
0.17
15
88
139
1281
1.28
0.84
4.8
4.2
9.6
12.2
mm/h
2.35
127
1165
171
1621
1.38
0.83
5.5
6.0
38.5
39.9
mmol/mol
1.70
157
1511
26
192
1.41
0.80
2.0
1.5
—
—
—
0
0
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
19
132
1.49
0.79
2.3
1.5
—
—
—
0
0
10
160
0.61
0.77
3.7
3.3
—
—
—
0
0
103
924
1.24
0.76
4.0
3.9
6.4
6.7
mmol/l
0.78
93
854
5
24
2.11
0.75
3.0
2.1
4.8
4.7
e9/l
—
5
24
5
24
2.11
0.75
3.0
2.8
63.8
61.7
%
—
5
24
9
55
1.67
0.74
1.4
1.8
—
—
—
0
0
17
117
1.50
0.74
3.8
3.0
—
—
—
0
0
16
109
1.51
0.73
1.6
1.3
—
—
—
0
0
25
327
0.73
0.72
1.3
1.3
10.9
15.1
u/ml
—
10
116
9
57
1.61
0.72
2.3
5.1
—
—
—
0
0
22
161
1.41
0.72
3.4
6.4
11.7
11.5
kpa
0.08
22
156
22
161
1.41
0.72
3.4
6.4
5.1
5.2
kpa
0.14
22
156
5
27
1.87
0.69
2.0
1.1
—
—
—
0
0
5
92
0.53
0.69
2.8
5.6
—
—
—
0
0
21
154
1.41
0.68
4.0
3.7
—
—
—
0
0
10
152
0.64
0.64
3.5
3.2
6.0
5.8
kpa
—
10
147
26
202
1.33
0.61
2.4
2.2
78.9
127.5
ug/g
0.87
15
160
17
124
1.41
0.58
1.8
2.3
67.1
67.6
e9/l
—
7
101
58
506
1.21
0.54
3.3
3.7
—
—
—
0
0
70
623
1.19
0.52
10.2
9.4
1.2
1.3
inr
0.28
23
166
58
657
0.83
0.52
2.8
3.6
30.7
89.3
ng/l
0.54
37
458
66
585
1.19
0.52
2.5
3.1
—
—
—
0
0
9
65
1.40
0.51
1.0
1.1
—
6.2
—
0
5
14
101
1.42
0.51
1.5
1.5
—
—
—
0
0
12
84
1.46
0.50
4.3
7.8
93.7
93.6
%
0.02
12
84
137
1442
0.84
0.50
22.3
15.5
329.9
331.3
g/l
1.08
137
1435
7
45
1.58
0.49
1.7
1.3
59.4
59.2
pmol/l
—
7
45
37
314
1.22
0.45
6.6
3.8
2.9
2.0
ug/l
1.19
32
283
9
127
0.70
0.45
1.6
1.3
—
—
—
0
0
7
51
1.39
0.44
2.3
3.2
—
—
—
0
0
79
720
1.16
0.44
2.1
2.0
95.4
99.4
pmol/l
0.26
34
356
10
139
0.70
0.43
4.8
2.9
—
—
—
0
0
5
32
1.58
0.42
3.4
2.9
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
36
308
1.21
0.41
1.2
1.3
2.3
2.4
g/l
0.20
14
169
12
88
1.39
0.41
4.1
7.5
1.0
1.5
%
1.58
12
88
12
88
1.39
0.41
4.3
7.4
0.5
0.7
%
1.42
12
88
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.48
0.40
1.4
2.1
24.4
24.5
mmol/l
—
5
27
28
332
0.82
0.40
1.4
1.3
45.4
39.9
iu/ml
—
8
106
0
19
0.00
0.39
0.0
4.5
—
6.6
—
0
13
9
66
1.38
0.39
1.0
1.2
27.4
26.5
iu/l
—
9
59
167
1617
1.20
0.38
5.3
4.9
1.9
1.9
mu/l
0.17
159
1475
22
180
1.25
0.38
4.1
5.2
104.3
104.1
mmol/l
0.09
22
175
79
728
1.14
0.37
2.8
2.7
130.6
97.1
ug/l
0.95
73
672
39
342
1.17
0.35
3.2
3.6
65.2
174.0
ng/l
0.52
29
257
88
820
1.13
0.34
4.7
5.0
0.0
0.0
estimate
0.00
14
129
6
90
0.66
0.33
1.7
3.6
—
—
—
0
0
143
1375
1.14
0.33
4.3
4.0
15.0
14.8
pmol/l
0.46
135
1256
169
1644
1.18
0.32
3.8
4.2
1.3
1.3
mmol/l
0.29
155
1501
88
833
1.10
0.24
3.3
3.6
0.0
0.0
estimate
0.00
15
127
178
1747
1.17
0.24
13.5
11.3
—
—
—
0
0
43
393
1.12
0.23
2.7
2.2
2.4
3.2
mg/l
1.92
37
333
0
11
0.00
0.21
0.0
1.0
—
28.5
—
0
11
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
22.7
—
0
10
0
10
0.00
0.21
0.0
1.5
—
9.2
—
0
10
54
502
1.10
0.21
1.5
1.7
1.5
1.3
mmol/l
0.47
47
433
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
1.8
—
0
13
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
49
524
0.91
0.18
4.0
3.0
—
—
—
0
0
85
814
1.08
0.17
3.4
3.6
0.0
0.0
estimate
0.00
15
133
57
538
1.08
0.16
2.8
3.0
10.7
170.4
mg/l
0.68
33
324
7
87
0.80
0.15
2.7
2.2
1.6
1.0
%
—
7
87
63
661
0.93
0.15
3.6
3.4
—
—
—
0
0
14
122
1.16
0.14
1.3
1.3
—
—
—
0
0
9
107
0.83
0.13
1.3
2.8
—
—
—
0
0
43
455
0.93
0.12
2.6
3.2
—
—
—
0
0
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
38
363
1.06
0.08
1.2
1.3
2.4
1.8
u/ml
—
9
99
119
1210
0.96
0.07
4.0
3.8
—
—
—
0
0
8
75
1.07
0.07
2.1
1.9
—
—
—
0
0
8
78
1.03
0.07
2.4
1.4
—
—
—
0
0
34
325
1.06
0.06
1.8
1.7
1238.2
1211.7
nmol/l
0.04
19
241
12
109
1.11
0.06
1.4
1.3
—
—
—
0
0
11
102
1.08
0.03
2.3
2.4
—
—
—
0
0
57
560
1.02
0.02
2.7
2.9
6.8
7.1
mmol/l
0.18
47
464
56
569
0.98
0.02
3.8
3.8
1.9
6.7
mg/mmol
2.29
32
337
39
383
1.02
0.01
4.2
3.5
—
—
—
0
0
12
126
0.95
0.00
1.0
1.2
82.2
116.9
iu/ml
—
6
59
24
246
0.97
0.00
1.3
1.2
—
—
—
0
0
13
126
1.03
0.00
1.1
1.2
—
—
—
0
0
43
427
1.01
0.00
3.9
3.7
0.0
0.0
estimate
0.00
13
126
37
365
1.02
0.00
1.6
1.7
526.2
455.6
pmol/l
0.67
32
303
18
178
1.01
0.00
1.9
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
0.00
0.0
6.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
23.7
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
6
64
0.94
0.00
2.2
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
5.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: CD2_INSITU_MELANOMA_LOWERLIMB_EXALLC – Melanoma in situ of lower limb, including hip

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).